Jingna Xun

1.9k total citations
33 papers, 738 citations indexed

About

Jingna Xun is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jingna Xun has authored 33 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Jingna Xun's work include HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (5 papers). Jingna Xun is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (5 papers). Jingna Xun collaborates with scholars based in China, Germany and United States. Jingna Xun's co-authors include Jun Chen, Yun Ling, Hongzhou Lu, Shibo Jiang, Jinghe Huang, Yumei Wen, Mei Liu, Qimin Wang, Shuai Xia and Lu Lu and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Jingna Xun

28 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingna Xun China 13 484 168 108 82 71 33 738
Yanqiu Lu China 13 369 0.8× 91 0.5× 177 1.6× 36 0.4× 44 0.6× 54 631
Yanhong Sun China 10 460 1.0× 128 0.8× 77 0.7× 53 0.6× 13 0.2× 25 664
Sijia He China 12 398 0.8× 101 0.6× 89 0.8× 131 1.6× 108 1.5× 37 773
Felipe Pérez‐García Spain 15 386 0.8× 111 0.7× 190 1.8× 45 0.5× 16 0.2× 35 587
Andrea Mastrángelo Italy 10 170 0.4× 60 0.4× 78 0.7× 42 0.5× 100 1.4× 21 380
Maha Al-Mozaini Saudi Arabia 12 208 0.4× 84 0.5× 73 0.7× 152 1.9× 63 0.9× 32 536
Isabella Bon Italy 16 480 1.0× 87 0.5× 143 1.3× 79 1.0× 388 5.5× 74 770
Sen Wang China 16 515 1.1× 242 1.4× 378 3.5× 126 1.5× 26 0.4× 43 834
Rob Fanter United States 12 217 0.4× 293 1.7× 280 2.6× 23 0.3× 131 1.8× 30 723

Countries citing papers authored by Jingna Xun

Since Specialization
Citations

This map shows the geographic impact of Jingna Xun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingna Xun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingna Xun more than expected).

Fields of papers citing papers by Jingna Xun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingna Xun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingna Xun. The network helps show where Jingna Xun may publish in the future.

Co-authorship network of co-authors of Jingna Xun

This figure shows the co-authorship network connecting the top 25 collaborators of Jingna Xun. A scholar is included among the top collaborators of Jingna Xun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingna Xun. Jingna Xun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jinfeng, Tangkai Qi, Jingna Xun, et al.. (2025). Monocyte distribution width (MDW) as a reliable diagnostic biomarker for sepsis in patients with HIV. Emerging Microbes & Infections. 14(1). 2479634–2479634.
2.
Yang, Xinyi, Yuqi Zhu, Xiaying Zhao, et al.. (2025). RYBP promotes HIV-1 latency through promoting H2AK119ub and decreasing H3K4me3. Cell Communication and Signaling. 23(1). 222–222.
3.
Wu, Luling, Jingna Xun, Benno Pütz, et al.. (2025). Predictive survival modelings for HIV-related cryptococcosis: comparing machine learning approaches. Frontiers in Cellular and Infection Microbiology. 15. 1542707–1542707.
4.
Wu, Luling, Benno Pütz, Renfang Zhang, et al.. (2024). Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system. Infection. 52(5). 1875–1887. 2 indexed citations
5.
Chen, Kai, Jiangrong Wang, Jingna Xun, et al.. (2024). Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV. BMC Infectious Diseases. 24(1). 97–97. 5 indexed citations
6.
Zhu, Yuqi, Xinyi Yang, Liang Yue, et al.. (2024). Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS. European Journal of Pharmaceutics and Biopharmaceutics. 201. 114353–114353. 2 indexed citations
7.
Yang, Junyang, Jingna Xun, Renfang Zhang, et al.. (2023). Elevated indoleamine 2,3-dioxygenase activity is associated with endothelial dysfunction in people living with HIV and ROS production in human aortic endothelial cells <i>in vitro </i>. Drug Discoveries & Therapeutics. 17(5). 312–319. 1 indexed citations
8.
Wang, Jing, Yanan Wang, Hanyu Pan, et al.. (2023). Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences. 24(6). 5424–5424. 11 indexed citations
9.
Xun, Jingna, et al.. (2022). Significance of initiating antiretroviral therapy in the early stage of HIV infection. Journal of Zhejiang University (Medical Sciences). 51(3). 373–379.
10.
Xun, Jingna, Rong Chen, Qi Tang, et al.. (2022). Circulating (1 → 3)-β-D-Glucan as an immune activation marker decreased after ART in people living with HIV. Frontiers in Public Health. 10. 981339–981339. 2 indexed citations
11.
Liu, Danping, Ling Gu, Renfang Zhang, et al.. (2022). Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients. International Journal of Infectious Diseases. 118. 65–70. 7 indexed citations
12.
Liu, Li, Zichen Song, Jingna Xun, et al.. (2022). PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person With HIV. Open Forum Infectious Diseases. 10(1). 4 indexed citations
13.
Lu, Panpan, Jinlong Yang, Xinyi Yang, et al.. (2022). EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice. Nanotheranostics. 6(3). 325–336. 2 indexed citations
14.
Qi, Tangkai, et al.. (2021). Untargeted GC/TOFMS unravel metabolic profiles in cerebrospinal fluid of Chinese people living with HIV. Journal of Clinical Laboratory Analysis. 35(3). e23673–e23673. 3 indexed citations
15.
Xun, Jingna, et al.. (2021). Editing out HIV: application of gene editing technology to achieve functional cure. Retrovirology. 18(1). 39–39. 13 indexed citations
16.
Yan, Yan, Wei Zhao, Wei Liu, et al.. (2021). CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance. Journal of Gastroenterology. 56(8). 769–785. 21 indexed citations
17.
Wu, Fan, Mei Liu, Aojie Wang, et al.. (2020). Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Internal Medicine. 180(10). 1356–1356. 129 indexed citations
18.
Yan, Jingjing, Jingna Xun, Chong Chen, et al.. (2018). Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Virology Journal. 15(1). 1–1. 48 indexed citations
19.
Yang, Junyang, Qi Tang, Tangkai Qi, et al.. (2018). Characteristics and Outcomes of Acinetobacter baumannii Infections in Patients with HIV: A Matched Case-Control Study. Scientific Reports. 8(1). 15617–15617. 4 indexed citations
20.
Liu, Caizhi, et al.. (2015). Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice. Biochemical and Biophysical Research Communications. 465(2). 305–311. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026